ABVC Biopharma, Inc.

Historical 13F Holders

Symbol: ABVC
CUSIP: 00091F304
All holders as of: Q2 2026
Type: Equity
Class: COM NEW

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Every filing for 00091F304 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Lind Global Fund II LP 13G/A Amendment 4	3.2%	557,143	13G/A Amendment 4	8/13/2025 Event 6/30/2025
Lind Global Fund II LP	3.2%	557,143
Lind Global Partners II LLC	3.2%	557,143
Easton Jeff	3.2%	557,143
Eugene Jiang 13D/A Amendment 1	18.5%	131,159	13D/A Amendment 1	7/15/2025 Event 7/10/2025
Eugene Jiang 13D	17.4%	131,159	13D	6/3/2025 Event 5/13/2025
Lind Global Fund II LP 13G/A Amendment 3	9.9%	1,325,000	13G/A Amendment 3	2/14/2025 Event 12/31/2024
Lind Global Fund II LP	9.9%	1,325,000
Lind Global Partners II LLC	9.9%	1,325,000
Easton Jeff	9.9%	1,325,000

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	4	237 k	$251k	$0
2026 Q2	15	1.09 M	$1.72M	$18.3k
2026 Q1	14	817 k	$792k	$10.4k
2025 Q4	15	855 k	$1.82M	$42.8k
2025 Q3	14	785 k	$2.39M	$0
2025 Q2	10	367 k	$817k	$0
2025 Q1	11	287 k	$305k	$0
2024 Q4	14	409 k	$241k	$0
2024 Q3	10	228 k	$156k	$0
2024 Q2	12	220 k	$171k	$0
2024 Q1	9	254 k	$333k	$0
2023 Q4	9	111 k	$129k	$0
2023 Q3	10	76.8 k	$79.8k	$0